Invesaro

Stocks SCSC Financial statements

Financial statements

SCANSOURCE, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SCANSOURCE, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue3,5683,8463,2503,0483,1513,5303,7883,2603,0413,226
Cost of revenue3,1852,7952,8572,6922,8003,1033,3382,8612,6322,789
Gross profit384369393356351427449399409437
Selling, general and administrative265232244260247275286277287313
Operating income88.26994.7-6561.512213690.385.298.6
Interest expense3.229.1213.212.26.936.5219.8138.016.59
Interest income5.333.711.825.833.14.337.419.3811.212.3
Other non-operating income11.1-0.550.25-0.41-0.12-1.35-1.66-0.995.96-0.56
Pre-tax income1016383.6-71.857.511912299.894.4104
Income tax32.227.618.87.4512.129.933.822.822.824.9
Income from continuing operations35.564.9-79.245.488.788.177.171.5
Net income69.233.257.6-19310.888.889.877.171.578.9
EBITDA113103128-29.695152165118115122
EPS, basic2.741.302.25-7.590.423.483.573.103.053.69
EPS, diluted2.711.292.24-7.590.423.453.543.063.003.64
Shares, basic (weighted)25.325.525.625.425.425.525.124.923.421.4
Shares, diluted (weighted)25.525.625.725.425.525.825.425.223.821.7

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents56.125.519.329.562.73836.218512688.4
Receivables637646523443569729753582636770
Inventory531596554455470615758513484522
Other current assets56.321.312.316.511.615.315.512.39.212.3
Total current assets1,2811,3621,4771,2031,2201,5241,6571,4051,3701,508
Property, plant and equipment56.67360.655.642.837.537.433.531.234.9
Lease right-of-use assets23.619.216.212.59.0610.38.85
Goodwill201289311214219214217206231245
Intangible assets10213712112210584.468.537.662.964.4
Other non-current assets48.852.952.972.563.661.670.87771.569.7
Total assets1,7181,9452,0671,6921,6721,9372,0681,7791,7861,932
Accounts payable513563488454635714691588599753
Accrued liabilities10590.964.676.787.888.578.965.671.386.5
Deferred revenue20.513.812.19.759.648.647.065.565.02
Short-term debt00.554.097.847.8411.66.927.867.862.87
Total current liabilities656710701719733814787669683859
Long-term debt5.434.8815114313512414413612898.5
Lease liabilities20.816.613.19.336.516.974.93
Other non-current liabilities42.252.757.280.168.353.949.349.250.251.8
Total liabilities8811,0791,1531,0149401,1311,1638558791,022
Total debt97.3249155151143135151144136101
Paid-in capital61.268.264.3
Retained earnings8498829407477588479371,0141,0211,018
Other comprehensive income-73.2-84.2-90.1-133-98.1-105-89.6-116-114-107
Shareholders' equity837866914678731807905924906911
Total equity837866914678731807905924906911
Total liabilities and equity1,7181,9452,0671,6921,6721,9372,0681,7791,7861,932
Shares outstanding25.425.625.425.425.525.224.824.222.220.2

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income69.233.257.6-19310.888.889.877.171.578.9
Depreciation and amortization2534.533.735.333.529.928.62830.223.6
Stock-based compensation6.66.386.055.488.0411.711.29.5411.114.1
Deferred income tax-1.78-21.9-1.56-10.90.883.9-2.24-2.032.814.57
Change in receivables-62.7-35.9-5.4957.5-119-166-17.4138-55-133
Change in inventory28.4-53.2-85.986.2-12.3-146-13823928.9-36.7
Change in payables19.937.316.1-20.817583-30.7-78.23.67151
Cash from operations94.924.8-27.1182117-124-35.8372112123
Capital expenditures-8.85-7-5.8-6.39-2.36-6.85-9.98-8.56-8.29-9.29
Acquisitions-83.8-144-32.2-48.90000-56.7-18.2
Cash from investing-96.2-152-39.4-55.332-3.72-8.269.05-62.4-27.5
Debt issued00150
Debt repaid00
Stock issued9.972.271.510.750.452.30.914.819.514.96
Share buybacks-20.90-9.48-6.080-18.2-15.7-42.9-107-97.9
Cash from financing-3.5110164.2-153-11910839.5-228-111-134
Exchange rate effect-0.44-4.020.56
Net change in cash-5.31-30.6-1.7110.628.3-24.7-1.81149-59.3-37.8
Free cash flow8617.8-32.9176114-131-45.7363104114
Interest paid2.838.6113.2126.416.0718.8137.576.1
Income taxes paid31.13630.616.91229.428.527.127.828.9

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $58.30 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin13.6%Gross profit / revenue.
Operating margin3.1%Operating income / revenue.
EBITDA margin3.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin3.2%Pre-tax income / revenue.
Net margin2.4%Net income / revenue.
FCF margin3.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin3.8%Cash from operations / revenue.
Effective tax rate24.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)8.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.2%Net income / average total assets.
Return on invested capital (ROIC)8.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue9.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.3%Capital expenditures / revenue.
D&A / revenue0.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-5.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y0.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y7.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-0.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y4.5%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y15.8%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-10.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y9.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y5.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-9.4%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y5.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y10.2%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-4.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y48.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y21.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y0.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y54.0%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y9.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y1.1%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y9.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-0.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y0.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.5%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y8.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-2.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y2.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-9.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-5.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.76xCurrent assets / current liabilities.
Quick ratio1.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.10x(Cash + short-term investments) / current liabilities.
Debt / equity0.11xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets5.2%Total debt / total assets.
Liabilities / assets52.9%Total liabilities / total assets.
Net debt$13.0MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.11xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage15.0xOperating income / interest expense.
Working capital$648.9MCurrent assets - current liabilities.
Goodwill and intangibles / assets16.0%(Goodwill + intangible assets) / total assets.
Tangible book value$601.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.74xRevenue / average total assets.
Fixed asset turnover97.7xRevenue / average property, plant and equipment.
Inventory turnover5.54xCost of revenue / average inventory.
Days inventory66 days365 x average inventory / cost of revenue.
Receivables turnover4.59xRevenue / average receivables.
Days sales outstanding79 days365 x average receivables / revenue.
Days payables88 days365 x average accounts payable / cost of revenue.
Cash conversion cycle57 daysDays inventory + days sales outstanding - days payables.
FCF conversion144.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow7.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.64Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$3.69Net income per basic share, as reported (split-adjusted).
Revenue per share$148.72Revenue / diluted weighted shares.
FCF per share$5.25Free cash flow / diluted weighted shares.
Operating cash flow per share$5.68Cash from operations / diluted weighted shares.
Book value per share$45.17Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$29.83Tangible book value / shares outstanding.
Cash per share$4.38(Cash + short-term investments) / shares outstanding.
Buybacks / FCF86.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.18BShare price x shares outstanding.
Enterprise value$1.20BMarket cap + total debt - cash - short-term investments.
P/E15.0xMarket cap / net income. Only when net income is positive.
P/S0.37xMarket cap / revenue.
P/B1.30xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.97xMarket cap / tangible book value, when positive.
P/FCF10.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF9.62xMarket cap / cash from operations, when positive.
EV/Sales0.37xEnterprise value / revenue.
EV/EBIT12.1xEnterprise value / operating income, when both are positive.
EV/EBITDA9.80xEnterprise value / EBITDA, when both are positive.
EV/FCF10.5xEnterprise value / free cash flow, when both are positive.
FCF yield9.6%Free cash flow / market cap.
Earnings yield6.7%Net income / market cap (the inverse of P/E).
Shareholder yield8.3%(Dividends paid + share buybacks) / market cap.
PEG16.1xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was SCANSOURCE, INC.'s revenue in fiscal 2026?

SCANSOURCE, INC. reported revenue of $3.23B for fiscal 2026, 6.1% higher than the year before.

Was SCANSOURCE, INC. profitable in fiscal 2026?

Yes. Net income was $78.9M, a net margin of 2.4%.

How much free cash flow did SCANSOURCE, INC. generate in fiscal 2026?

Cash from operations of $123.1M minus capital expenditures of $9.3M left free cash flow of $113.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SCANSOURCE, INC.